» Articles » PMID: 24569455

Familial Alzheimer's Disease-associated Presenilin-1 Alters Cerebellar Activity and Calcium Homeostasis

Abstract

Familial Alzheimer's disease (FAD) is characterized by autosomal dominant heritability and early disease onset. Mutations in the gene encoding presenilin-1 (PS1) are found in approximately 80% of cases of FAD, with some of these patients presenting cerebellar damage with amyloid plaques and ataxia with unclear pathophysiology. A Colombian kindred carrying the PS1-E280A mutation is the largest known cohort of PS1-FAD patients. Here, we investigated PS1-E280A-associated cerebellar dysfunction and found that it occurs early in PS1-E208A carriers, while cerebellar signs are highly prevalent in patients with dementia. Postmortem analysis of cerebella of PS1-E280A carrier revealed greater Purkinje cell (PC) loss and more abnormal mitochondria compared with controls. In PS1-E280A tissue, ER/mitochondria tethering was impaired, Ca2+ channels IP3Rs and CACNA1A were downregulated, and Ca2+-dependent mitochondrial transport proteins MIRO1 and KIF5C were reduced. Accordingly, expression of PS1-E280A in a neuronal cell line altered ER/mitochondria tethering and transport compared with that in cells expressing wild-type PS1. In a murine model of PS1-FAD, animals exhibited mild ataxia and reduced PC simple spike activity prior to cerebellar β-amyloid deposition. Our data suggest that impaired calcium homeostasis and mitochondrial dysfunction in PS1-FAD PCs reduces their activity and contributes to motor coordination deficits prior to Aβ aggregation and dementia. We propose that PS1-E280A affects both Ca2+ homeostasis and Aβ precursor processing, leading to FAD and neurodegeneration.

Citing Articles

Inflammasomes in Alzheimer's Progression: Nrf2 as a Preventive Target.

Lopez-Hernandez R, de la Torre-Alamo M, Garcia-Bueno B, Baroja-Mazo A, Fenoy F, Cuevas S Antioxidants (Basel). 2025; 14(2).

PMID: 40002308 PMC: 11851705. DOI: 10.3390/antiox14020121.


Cerebellum in neurodegenerative diseases: Advances, challenges, and prospects.

Liu G, Yang C, Wang X, Chen X, Cai H, Le W iScience. 2024; 27(11):111194.

PMID: 39555407 PMC: 11567929. DOI: 10.1016/j.isci.2024.111194.


Dysregulated mTOR networks in experimental sporadic Alzheimer's disease.

de la Monte S, Tong M Front Cell Neurosci. 2024; 18:1432359.

PMID: 39386180 PMC: 11461251. DOI: 10.3389/fncel.2024.1432359.


Monoclonal antibodies and aptamers: The future therapeutics for Alzheimer's disease.

Barrera-Ocampo A Acta Pharm Sin B. 2024; 14(7):2795-2814.

PMID: 39027235 PMC: 11252463. DOI: 10.1016/j.apsb.2024.03.034.


Cerebellum in Alzheimer's disease and other neurodegenerative diseases: an emerging research frontier.

Yang C, Liu G, Chen X, Le W MedComm (2020). 2024; 5(7):e638.

PMID: 39006764 PMC: 11245631. DOI: 10.1002/mco2.638.


References
1.
Wilson C, Murphy D, Giasson B, Zhang B, Trojanowski J, Lee V . Degradative organelles containing mislocalized alpha-and beta-synuclein proliferate in presenilin-1 null neurons. J Cell Biol. 2004; 165(3):335-46. PMC: 2172178. DOI: 10.1083/jcb.200403061. View

2.
Area-Gomez E, de Groof A, Boldogh I, Bird T, Gibson G, Koehler C . Presenilins are enriched in endoplasmic reticulum membranes associated with mitochondria. Am J Pathol. 2009; 175(5):1810-6. PMC: 2774047. DOI: 10.2353/ajpath.2009.090219. View

3.
Grice K, Vogel K, Le V, Mitchell A, Muniz S, Vollmer M . Adult norms for a commercially available Nine Hole Peg Test for finger dexterity. Am J Occup Ther. 2003; 57(5):570-3. DOI: 10.5014/ajot.57.5.570. View

4.
Larner A, Doran M . Clinical phenotypic heterogeneity of Alzheimer's disease associated with mutations of the presenilin-1 gene. J Neurol. 2005; 253(2):139-58. DOI: 10.1007/s00415-005-0019-5. View

5.
Velazquez-Perez L, Diaz R, Perez-Gonzalez R, Canales N, Rodriguez-Labrada R, Medrano J . Motor decline in clinically presymptomatic spinocerebellar ataxia type 2 gene carriers. PLoS One. 2009; 4(4):e5398. PMC: 2671146. DOI: 10.1371/journal.pone.0005398. View